Compare PXED & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PXED | AORT |
|---|---|---|
| Founded | 1976 | 1984 |
| Country | United States | United States |
| Employees | 3400 | 1800 |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | 1996 |
| Metric | PXED | AORT |
|---|---|---|
| Price | $29.00 | $23.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $44.29 | ★ $49.40 |
| AVG Volume (30 Days) | 79.5K | ★ 691.6K |
| Earning Date | 04-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $3.85 | $14.20 |
| Revenue Next Year | $4.49 | $11.20 |
| P/E Ratio | ★ $11.20 | $767.67 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $23.52 | $19.16 |
| 52 Week High | $38.19 | $48.25 |
| Indicator | PXED | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 26.54 |
| Support Level | $28.60 | $19.16 |
| Resistance Level | $30.85 | $38.43 |
| Average True Range (ATR) | 1.40 | 1.95 |
| MACD | 0.02 | -1.17 |
| Stochastic Oscillator | 46.88 | 26.26 |
Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.